| Jennifer C Jackson, MD | |
|
200 Clinic Dr, Madisonville, KY 42431-1661 | |
| (270) 825-7200 | |
| Not Available |
| Full Name | Jennifer C Jackson |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 200 Clinic Dr, Madisonville, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417054040 | NPI | - | NPPES |
| 23527 | Other | KY | LICENSE |
| 000000044291 | Other | BCBS PROVIDER NUMBER | |
| 64235278 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 23527 (Kentucky) | Primary |
| 2083X0100X | Preventive Medicine - Occupational Medicine | 23527 (Kentucky) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer C Jackson, MD 200 Clinic Dr, Madisonville, KY 42431-1661 Ph: (270) 825-7200 | Jennifer C Jackson, MD 200 Clinic Dr, Madisonville, KY 42431-1661 Ph: (270) 825-7200 |
News Archive
A new emergency department study from the University of Michigan Injury Center looks deeper at risk and protective factors among teenagers who report dating violence and alcohol use.
A team of researchers led by Fatih M. Uckun, MD, PhD, of The Saban Research Institute of Children's Hospital Los Angeles and Professor at the University of Southern California Keck School of Medicine has determined that radiation resistance in leukemia can be overcome by using an engineered protein they recently designed and developed as a new precision medicine against leukemia.
Neurowave Medical Technologies™ today announced the release of an innovative new device for the treatment of post-operative nausea, medically referred to as emesis. Reletex™ is a novel transdermal neuromodulation device that is non-invasive and drug-free, and has been demonstrated to alleviate nausea when used as an adjunct to anti-emetics.
An international team of scientists, including researchers from the National Institute of Allergy and Infectious Diseases (NIAID), report using antibodies derived from immune cells from recent human survivors of H5N1 avian influenza to successfully treat H5N1-infected mice as well as protect them from an otherwise lethal dose of the virus.
Emergent BioSolutions Inc. today announced that it has received a multi-year grant from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to advance the development of MVA85A, a candidate vaccine against tuberculosis.
› Verified 3 days ago
Kristin Wickham, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Clinic Dr, Madisonville, KY 42431 Phone: 270-825-7200 | |
Robert G. Holzknecht, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 444 S Main St, Madisonville, KY 42431 Phone: 270-821-4444 Fax: 270-821-9188 | |
Richard G King, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 200 Clinic Dr, Madisonville, KY 42431 Phone: 270-825-7200 | |
Catherine S Montz, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 200 Clinic Dr, Madisonville, KY 42431 Phone: 270-825-6680 Fax: 270-825-7266 | |
Michael Jones, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 230 Madison Square Dr Ste C, Madisonville, KY 42431 Phone: 270-821-6262 | |
Robert Lamont Wood, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Clinic Dr, Madisonville, KY 42431 Phone: 270-825-6680 Fax: 270-825-7266 | |
Marium Iqbal, Family Medicine Medicare: Medicare Enrolled Practice Location: 200 Clinic Dr, Madisonville, KY 42431 Phone: 270-825-6680 Fax: 270-825-7266 |